Evacetrapib ≥95% (by HPLC)
Synonyms:
4-trans-(((S)-5-((3,5-Bis(trifluoromethyl)benzyl)(2-methyl-2H-tetrazol-5-yl)amino)-7,9-dimethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)methyl)cyclohexanecarboxylic acid
, trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]- cyclohexanecarboxylic acid
, LY2484595
Evacetrapib is a potent, and selective CETP (cholesteryl ester transfer protein) inhibitor. It inhibits human recombinant CETP protein (IC₅₀ = 5.5 nM ) and CETP activity in human plasma (IC₅₀ = 36 nM) in vitro. Unlike Torcetrapib (Cat. No. 2420 & 2533), Evacetrapib does not induce aldosterone or cortisol biosynthesis.
- Formulation: Crystalline solid
Formula:
C₃₁H₃₆F₆N₆O₂ MW: 638.65 g/mol Storage Temperature: Freezer |
MDL Number:
MFCD23105886 CAS Number: 1186486-62-3 |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...